Doctor’s comments on AIDS – HIV and transfer factors
Rob Robertson, M.D. “AIDS is a viral attack on certain immune system cells, which causes an inability of our immune system to mount a normal response to infectious agents. Thus persons who have AIDS are susceptible to opportunistic infections caused by pathogens ordinarily, in the non-immunodeficient patient, would be benign, or at least not life threatening. Transfer Factor Plus, by its ability to generally stimulate the immune system, and by its particular ability to increase the function of viral fighting Natural Killer Cells, should certainly be strongly considered as an adjuvant to be added to the arsenal of regimens used in the intervention of the progressive course of AIDS.”
Dr. William Hennen: “The use of a general transfer factor preparation is well justified for preventative use. Much of what we have seen in the cases of AIDS and even the flu is that it is not the primary infection that kills, but rather the secondary, opportunistic infections that destroy the weakened individual.”
David Markowitz, M.D. An experience with HIV – Kenny’s Story: An early success with Immune Boosting naturally in a young man with HIV. KG is a 20 year old with Hemophilia who contracted HIV many years ago from “dirty” clotting factors used to treat his Hemophilia. KG has been on many regimens for his HIV, including most recently (within the past year), an experimental regimen with no positive response. If anything, he suffered from many of the side effects of retroviral therapy. Five months ago, KG started a high dose regimen of Transfer Factor™ (3 caps 3 times daily) and Transfer Factor Plus™ (2 caps 3 times daily), concurrent with his experimental therapy. He has remained infectious disease free throughout his TF boosting. He also came to us with very exciting news three weeks ago: he has a ZERO viral count and an increasing, now close to normal CD4 count of 475. Is Kenny out of the woods completely? No, but he is now well on his way to possibly being disease free. His next counts are scheduled for six weeks from now and we will keep all posted. Kenny is a peer counselor and educator for HIV/AIDS and he is now spreading the word about TF and TF+ to members of the AIDS community.
“An international Transfer Factor symposium was held which highlighted the recent work of determined scientists.” Source: Transfer Factor in the Era of Aids. Proceedings of the Xth Ibnternational Symposium on Transfer Factor. Bologna, Italy, 22-24 June 1995. Biotherapy 1996, 9(1-3), ix-x, 1-185.
“Using Transfer Factor, an 80 percent inhibition of HIV was demonstrated in vitro. Interestingly, these researchers seperated the Transfer Factor into three fractions and found that all of the anti-HIV activity was located in one fraction.” Source: Inhibition of in vitro HIV infection by dialyzable leukocyte extracts. Fernandez-Ortega C, Dubed M, Ruibal O, Villarrubia OK, Menendez de San Pedro JC, Navea L, Ojeda M, Arana MJ. Biotherapy 1996, 9(1-3), 33-40.
“In a combination protocol, HIV-1 specific Transfer Factor with Zidovudine (ZDV) administration orally for 15 days resulted in an increase in white blood cells, CD8 lymphocytes and IL-2 levels, which worked to fight the virus. The combination ZDV and Transfer Factor appeared to be both safe and well tolerated.” Source: Preliminerary results in HIV-1-infected patients treated with Transfer Factor (TF) and zidovudine (ZDV). Raise E, Guerra L, Viza D, Pizza G, De Vinci C, Schiattone ML, Rocaccio L, Cicognani M, Gritti F. Biotherapy 1996, 9(1-3), 49-54.
“The benefits of a combination therapy of antiviral treatments and daily Transfer Factor administration were further demonstrated by a resotration of delayed type hypersensitivity within 60 days.” Source: Preliminary observations using HIV-specific Transfer Factor in Airds. Pizza G, Chiodo F, Colangeli M, Raiwe E, Fudenberg HH, De Vinci C, Viza D. Biotherapy 1996, 9(1-3), 163-170.
